Opus Genetics, Inc. 8-K

What Happened Opus Genetics, Inc. announced via Form 8-K (filed June 16, 2026) that management delivered a corporate presentation at the company's Virtual R&D Science Forum on June 16, 2026. The presentation is attached to the filing as Exhibit 99.1 and a webcast and slide deck are available through Opus Genetics’ investor relations site (https://ir.opusgtx.com) under “Events.”

Key Details

• Event: Virtual R&D Science Forum presentation delivered by Opus Genetics’ management on June 16, 2026.
• Filing: Disclosure made under Item 7.01 (Regulation FD disclosure) of Form 8-K; presentation attached as Exhibit 99.1.
• Access: Webcast and slides posted on the company’s investor relations “Events” page: https://ir.opusgtx.com.
• Additional filing technical item: Inline XBRL cover page included (Exhibit 104.1).

Why It Matters This Form 8-K signals the company provided an investor-facing update focused on research and development progress. For retail investors, the presentation and webcast are primary sources to review management’s statements about Opus Genetics’ pipeline, milestones, timelines and scientific strategy. The posted materials let investors hear the company’s latest R&D messaging directly and may help when evaluating Opus Genetics’ near-term catalysts and progress.